전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Articles Service

Supplementary
Share this article on :

Related articles in JMB

More Related Articles

Research article

References

  1. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, et al. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4: 69-77.
    Pubmed CrossRef
  2. Lazear HM, Nice TJ, Diamond MS. 2015. Interferon-lambda: immune functions at barrier surfaces and beyond. Immunity 43: 15-28.
    Pubmed PMC CrossRef
  3. Sang Y, Rowland RR, Blecha F. 2010. Molecular characterization and antiviral analyses of porcine type III interferons. J. Interferon Cytokine Res. 30: 801-807.
    Pubmed CrossRef
  4. Pott J, Mahlakoiv T, Mordstein M, Duerr CU, Michiels T, Stockinger S, et al. 2011. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. USA 108: 7944-7949.
    Pubmed PMC CrossRef
  5. Wang D, Fang L, Xiao S. 2016. Porcine epidemic diarrhea in China. Virus Res. 226: 7-13.
    Pubmed PMC CrossRef
  6. Zhang Q, Hu R, Tang X, Wu C, He Q, Zhao Z, et al. 2013. Occurrence and investigation of enteric viral infections in pigs with diarrhea in China. Arch. Virol. 158: 1631-1636.
    Pubmed CrossRef
  7. Zhao ZP, Yang Z, Lin WD, Wang WY, Yang J, Jin WJ, et al. 2016. The rate of co-infection for piglet diarrhea viruses in China and the genetic characterization of porcine epidemic diarrhea virus and porcine kobuvirus. Acta Virol. 60: 55-61.
    Pubmed CrossRef
  8. Al Kassaa I, Hober D, Hamze M, Chihib NE, Drider D. 2014. Antiviral potential of lactic acid bacteria and their bacteriocins. Probiotics Antimicrob. Proteins 6: 177-185.
    Pubmed CrossRef
  9. Seo BJ, Rather IA, Kumar VJ, Choi UH, Moon MR, Lim JH, et al. 2012. Evaluation of Leuconostoc mesenteroides YML003 as a probiotic against low-pathogenic avian influenza (H9N2) virus in chickens. J. Appl. Microbiol. 113: 163-171.
    Pubmed CrossRef
  10. Lakshmi B, Viswanath B, Sai Gopal DV. 2013. Probiotics as antiviral agents in shrimp aquaculture. J. Pathog. 2013: 424123.
    Pubmed PMC CrossRef
  11. Al Kassaa I, Hamze M, Hober D, Chihib NE, Drider D. 2014. Identification of vaginal lactobacilli with potential probiotic properties isolated from women in North Lebanon. Microb. Ecol. 67: 722-734.
    Pubmed CrossRef
  12. Wang Z, Chai W, Burwinkel M, Twardziok S, Wrede P, Palissa C, et al. 2013. Inhibitory influence of Enterococcus faecium on the propagation of swine influenza A virus in vitro. PLoS One 8: e53043.
    Pubmed PMC CrossRef
  13. Maragkoudakis PA, Chingwaru W, Gradisnik L, Tsakalidou E, Cencic A. 2010. Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection. Int. J. Food Microbiol. 141 Suppl 1: S91-97.
    Pubmed PMC CrossRef
  14. Cha MK, Lee DK, An HM, Lee SW, Shin SH, Kwon JH, et al. 2012. Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16. BMC Med. 10: 72.
    Pubmed PMC CrossRef
  15. Conti C, Malacrino C, Mastromarino P. 2009. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J. Physiol. Pharmacol. 60 (Suppl 6): 19-26.
  16. Martin V, Maldonado A, Fernandez L, Rodriguez JM, Connor RI. 2010. Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk. Breastfeed. Med. 153-158.
    Pubmed PMC CrossRef
  17. Arena MP, Capozzi V, Spano G, Fiocco D. 2017. The potential of lactic acid bacteria to colonize biotic and abiotic surfaces and the investigation of their interactions and mechanisms. Appl. Microbiol. Biotechnol. 101: 2641-2657.
    Pubmed CrossRef
  18. Sorvig E, Mathiesen G, Naterstad K, Eijsink VG, Axelsson L. 2005. High-level, inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum using versatile expression vectors. Microbiology (Reading, England). 151: 2439-2449.
    Pubmed CrossRef
  19. Dekie L, Toncheva V, Dubruel P, Schacht EH, Barrett L, Seymour LW. 2000. Poly-L-glutamic acid derivatives as vectors for gene therapy. J. Control. Release 65: 187-202.
    CrossRef
  20. Ashiuchi M, Nawa C, Kamei T, Song JJ, Hong SP, Sung MH, et al. 2001. Physiological and biochemical characteristics of poly gammaglutamate synthetase complex of Bacillus subtilis. Eur. J. Biochem. 268: 5321-5328.
    Pubmed CrossRef
  21. Hofmann M, Wyler R. 1988. Propagation of the virus of porcine epidemic diarrhea in cell culture. J. Clin. Microbiol. 26: 2235-2239.
    Pubmed PMC CrossRef
  22. Sun D, Shi H, Guo D, Chen J, Shi D, Zhu Q, et al. 2 015. Analysis of protein expression changes of the Vero E6 cells infected with classic PEDV strain CV777 by using quantitative proteomic technique. J. Virol. Methods 218: 27-39.
    Pubmed PMC CrossRef
  23. Shi SH, Yang WT, Yang GL, Cong YL, Huang HB, Wang Q, et al. 2014. Immunoprotection against influenza virus H9N2 by the oral administration of recombinant Lactobacillus plantarum NC8 expressing hemagglutinin in BALB/c mice. Virology 464-65: 166-176.
    Pubmed CrossRef
  24. Huang KY, Yang GL, Jin YB, Liu J, Chen HL, Wang PB, et al. 2018. Construction and immunogenicity analysis of Lactobacillus plantarum expressing a porcine epidemic diarrhea virus S gene fused to a DC-targeting peptide. Virus Res. 247: 84-93.
    Pubmed PMC CrossRef
  25. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3: 1101-1108.
    Pubmed CrossRef
  26. Thirabunyanon M, Hongwittayakorn P. 2013. Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Appl. Biochem. Biotechnol. 169: 511-525.
    Pubmed CrossRef
  27. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, Chilcote RR, et al. 1988. Homozygous deletion of the alphaand beta 1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA 85: 5259-5263.
    Pubmed PMC CrossRef
  28. Li L , Fu F , Xue M, Chen W, L iu J , Shi H, et al. 2 017. I FNlambda preferably inhibits PEDV infection of porcine intestinal epithelial cells compared with IFN-alpha. Antiviral Res. 140: 76-82.
    Pubmed PMC CrossRef
  29. Arena MP, Elmastour F, Sane F, Drider D, Fiocco D, Spano G, et al. 2018. Inhibition of coxsackievirus B4 by Lactobacillus plantarum. Microbiol. Res. 210: 59-64.
    Pubmed CrossRef
  30. Zhang X, Li P, Zheng Q, Hou J. 2019. Lactobacillus acidophilus S-layer protein-mediated inhibition of PEDVinduced apoptosis of Vero cells. Vet. Microbiol. 229: 159-167.
    Pubmed PMC CrossRef
  31. Kochs G, Haller O. 1999. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc. Natl. Acad. Sci. USA 96: 2082-2086.
    Pubmed PMC CrossRef
  32. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, et al. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. USA 104: 1371-1376.
    Pubmed PMC CrossRef
  33. Melchjorsen J, Kristiansen H, Christiansen R, Rintahaka J, Matikainen S, Paludan SR, et al. 2009. Differential regulation of the OASL and OAS1 genes in response to viral infections. J. Interferon Cytokine Res. 29: 199-207.
    Pubmed CrossRef
  34. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, et al. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
    Pubmed PMC CrossRef
  35. Diamond MS, Farzan M. 2013. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13: 46-57.
    Pubmed PMC CrossRef
  36. Wells JM, Mercenier A. 2008. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat. Rev. Microbiol. 6: 349-362.
    Pubmed PMC CrossRef
  37. Bermudez-Humaran LG, Cortes-Perez NG, Le Loir Y, Alcocer-Gonzalez JM, Tamez-Guerra RS, de Oca-Luna RM, et al. 2004. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J. Med. Microbiol. 53: 427-433.
    Pubmed CrossRef
  38. Michon C, Langella P, Eijsink VG, Mathiesen G, Chatel JM. 2016. Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications. Microb. Cell Fact. 15: 70.
    Pubmed PMC CrossRef
  39. Ma SJ, Li K, Li XS, Guo XQ, Fu PF, Yang MF, et al. 2014. Expression of bioactive porcine interferon-alpha in Lactobacillus casei. World J. Microbiol. Biotechnol. 30: 2379-2386.
    Pubmed CrossRef
  40. Masters PS. 2006. The molecular biology of coronaviruses. Adv. Virus Res. 66: 193-292.
    CrossRef
  41. Enjuanes L, Smerdou C, Castilla J, Anton IM, Torres JM, Sola I, et al. 1995. Development of protection against coronavirus induced diseases. A review. Adv. Exp. Med. Biol. 380: 197-211.
    Pubmed CrossRef
  42. Mullan BP, Davies GT, Cutler RS. 1994. Simulation of the economic impact of transmissible gastroenteritis on commercial pig production in Australia. Aust. Vet. J. 71: 151-154.
    Pubmed CrossRef
  43. Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, Artyomov M, et al. 2015. Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347: 269-273.
    Pubmed PMC CrossRef